Trial Number

086-20

Condition

Heart Failure

Participant Age Range

18 years and older

Participant Gender

Any

Enrolling Participants

Yes

Overview

Reducing Lung Congestion Symptoms using the V-Wave Shunt in Advanced Heart Failure: RELIEVE-HF

RELIEVE-HF is a global, 500 patient pivotal study of its proprietary, minimally invasive implanted interatrial shunt device for treating patients with NHYA Class III and ambulatory Class IV symptomatic heart failure (HF). This randomized, controlled, double-blinded multicenter clinical trial – the RELIEVE-HF study – will evaluate the safety and effectiveness of V-Wave’s novel device therapy in severe HF patients with either preserved or reduced ejection fraction.

Provider

Related Clinical Trials

Click on the category you are interested in.